Ruíz Francisco O, Pascual Liliana, Giordano Walter, Barberis Lucila
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Río Cuarto, 5800 Río Cuarto, Córdoba, Argentina Departamento de Microbiología e Inmunología, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, 5800 Río Cuarto, Córdoba, Argentina
Departamento de Microbiología e Inmunología, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, 5800 Río Cuarto, Córdoba, Argentina.
Pathog Dis. 2015 Apr;73(3). doi: 10.1093/femspd/ftv013. Epub 2015 Feb 11.
In the search of new antimicrobial agents against Neisseria gonorrhoeae, the bacteriocins-producing probiotic lactobacilli deserve special attention. The inhibitory effects of biosubstances such as organic acids, hydrogen peroxide and each bacteriocin-like inhibitory substance (BLIS) L23 and L60 on the growth of different gonococcal strains were investigated. Different non-treated and treated cell-free supernatants of two probiotic lactobacilli containing these metabolites were used. The aims of this work were (i) to evaluate the antimicrobial activity of the biosubstances produced by two probiotic lactobacilli, estimating the proportion in which each of them is responsible for the inhibitory effect, (ii) to define their minimum inhibitory concentrations (MICs) and, (iii) to determine the potential interactions between these biosubstances against N. gonorrhoeae. The main antimicrobial metabolites were the BLIS-es L23 and L60 in comparison with other biosubstances. Proportionally, their contributions to the inhibition on the gonococcal growth were 87.28% and 80.66%, respectively. The MIC values of bacteriocins were promising since these substances, when diluted, showed considerable inhibitory activity for all gonococci. In the interaction between bacteriocins, 100% of synergism was found on the gonococcal growth. In summary, this study indicates that both L23 and L60 could potentially serve to design new bioproducts against N. gonorrhoeae.
在寻找针对淋病奈瑟菌的新型抗菌剂时,产细菌素的益生菌乳酸杆菌值得特别关注。研究了有机酸、过氧化氢以及每种类细菌素抑制物质(BLIS)L23和L60等生物物质对不同淋球菌菌株生长的抑制作用。使用了含有这些代谢产物的两种益生菌乳酸杆菌未经处理和处理后的不同无细胞上清液。这项工作的目的是:(i)评估两种益生菌乳酸杆菌产生的生物物质的抗菌活性,估计它们各自对抑制作用的贡献率;(ii)确定它们的最低抑菌浓度(MIC);以及(iii)确定这些生物物质之间针对淋病奈瑟菌的潜在相互作用。与其他生物物质相比,主要的抗菌代谢产物是BLIS L23和L60。按比例计算,它们对淋球菌生长抑制的贡献率分别为87.28%和80.66%。细菌素的MIC值很有前景,因为这些物质稀释后对所有淋球菌都显示出相当大的抑制活性。在细菌素之间的相互作用中,发现对淋球菌生长有100%的协同作用。总之,这项研究表明L23和L60都有可能用于设计针对淋病奈瑟菌的新型生物制品。